EA200802288A1 - Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови - Google Patents

Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови

Info

Publication number
EA200802288A1
EA200802288A1 EA200802288A EA200802288A EA200802288A1 EA 200802288 A1 EA200802288 A1 EA 200802288A1 EA 200802288 A EA200802288 A EA 200802288A EA 200802288 A EA200802288 A EA 200802288A EA 200802288 A1 EA200802288 A1 EA 200802288A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
prevention
help
basis
composition
Prior art date
Application number
EA200802288A
Other languages
English (en)
Other versions
EA015942B1 (ru
Inventor
Йонгхонг Сонг
Чжаочжон Дж. Цзя
Энджейли Пэнди
Роберт М. Скарбара
Original Assignee
Милленниум Фамэсьютикэлс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Милленниум Фамэсьютикэлс, Инк. filed Critical Милленниум Фамэсьютикэлс, Инк.
Publication of EA200802288A1 publication Critical patent/EA200802288A1/ru
Publication of EA015942B1 publication Critical patent/EA015942B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

Настоящее изобретение направлено на соединения формулы (I) и их фармацевтически примлемые соли, эфиры и пролекарства, которые представляют собой ингибиторы фактора Ха. Настоящее изобретение также направлено на интермедиаты, применяемые при получении таких соединений, фармацевтические композиции, содержащие такие соединения, способы профилактики или лечения ряда заболеваний, характеризующихся нежелательным тромбообразованием, и способы ингибирования коагуляции образцов крови.
EA200802288A 2006-05-05 2007-05-04 Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови EA015942B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79795406P 2006-05-05 2006-05-05
US88366707P 2007-01-05 2007-01-05
PCT/US2007/068262 WO2007131179A1 (en) 2006-05-05 2007-05-04 Factor xa inhibitors

Publications (2)

Publication Number Publication Date
EA200802288A1 true EA200802288A1 (ru) 2009-04-28
EA015942B1 EA015942B1 (ru) 2011-12-30

Family

ID=38480433

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802288A EA015942B1 (ru) 2006-05-05 2007-05-04 Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови

Country Status (17)

Country Link
US (4) US7763608B2 (ru)
EP (1) EP2016072B1 (ru)
JP (1) JP5227311B2 (ru)
KR (1) KR20090010098A (ru)
CN (1) CN101490036B (ru)
AR (1) AR060768A1 (ru)
AU (1) AU2007247928B2 (ru)
BR (1) BRPI0711296A2 (ru)
CA (1) CA2651303A1 (ru)
EA (1) EA015942B1 (ru)
HK (1) HK1126490A1 (ru)
IL (1) IL194891A (ru)
MX (1) MX2008014193A (ru)
NZ (1) NZ572418A (ru)
TW (1) TW200813017A (ru)
WO (1) WO2007131179A1 (ru)
ZA (2) ZA200809362B (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064642A2 (en) * 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
US7696352B2 (en) 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
KR101195801B1 (ko) 2004-06-18 2012-11-05 밀레니엄 파머슈티컬스 인코퍼레이티드 Ｘａ 인자 억제제
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
US20080200431A1 (en) * 2005-07-08 2008-08-21 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa
WO2007008143A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
WO2007112367A2 (en) * 2006-03-27 2007-10-04 Portola Pharmaceuticals, Inc. Potassium channel modulators and platelet procoagulant activity
EA015942B1 (ru) 2006-05-05 2011-12-30 Милленниум Фамэсьютикэлс, Инк. Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови
ES2382055T3 (es) 2006-11-02 2012-06-04 Millennium Pharmaceuticals, Inc. Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa
JP2010515691A (ja) * 2007-01-05 2010-05-13 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 第Ｘａ因子阻害剤
EP2591783A1 (en) * 2007-04-13 2013-05-15 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
PT2146705E (pt) * 2007-05-02 2014-05-23 Portola Pharm Inc Terapia de combinação com um composto que atua como inibidor do recetor de adp de plaquetas
WO2009063029A2 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
US8530501B2 (en) * 2009-12-17 2013-09-10 Millennium Pharmaceuticals, Inc. Salts and crystalline forms of a factor Xa inhibitor
JP5766204B2 (ja) 2009-12-17 2015-08-19 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 第Ｘａ因子阻害剤の合成方法
US8742120B2 (en) 2009-12-17 2014-06-03 Millennium Pharmaceuticals, Inc. Methods of preparing factor xa inhibitors and salts thereof
US20110160250A1 (en) * 2009-12-17 2011-06-30 Millennium Pharmaceuticals, Inc. Crystalline forms of a factor xa inhibitor
AR082803A1 (es) 2010-09-01 2013-01-09 Portola Pharm Inc Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p
AR082804A1 (es) 2010-09-01 2013-01-09 Portola Pharm Inc Formas cristalinas de un inhibidor del factor xa
WO2013033370A1 (en) 2011-08-31 2013-03-07 Portola Pharmaceuticals, Inc. Prevention and treatment of thrombosis in medically ill patients
CN103242310A (zh) * 2012-02-10 2013-08-14 苏州迈泰生物技术有限公司 吡唑并吡啶酮类化合物及其在制备抗凝血药物中的用途
JP6186434B2 (ja) * 2012-07-18 2017-08-23 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 窒素複素環誘導体及びその医薬品への応用
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
PE20211303A1 (es) * 2012-12-24 2021-07-20 Coagulant Therapeutics Corp Polipeptidos del factor vii de accion corta
TWI633089B (zh) * 2013-03-28 2018-08-21 拜耳製藥股份有限公司 經取代的酮基吡啶衍生物
ES2663806T3 (es) 2013-12-19 2018-04-17 unshine Lake Pharma Co., Ltd. Derivados heterocíclicos nitrogenados y su aplicación en el tratamiento de la fibrosis tisular
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
CA2961981A1 (en) * 2014-09-24 2016-03-31 Bayer Pharma Aktiengesellschaft Substituted oxopyridine derivatives
WO2016146606A1 (de) * 2015-03-19 2016-09-22 Bayer Pharma Aktiengesellschaft Oxopyridin-derivate als faktor xia hemmer zur behandlung von thrombose
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
CA2991261A1 (en) * 2015-07-06 2017-01-12 Bayer Cropscience Aktiengesellschaft Nitrogenous heterocycles as a pesticide
JO3703B1 (ar) 2015-07-09 2021-01-31 Bayer Pharma AG مشتقات أوكسوبيريدين مستبدلة
US10148678B2 (en) 2015-10-01 2018-12-04 The Boeing Company Cybersecurity system with differentiated capacity to deal with complex cyber attacks
PT3395801T (pt) * 2015-12-16 2021-05-24 Nippon Soda Co Composto de arilazol e agente de controlo de pragas
CN105753804A (zh) * 2016-04-15 2016-07-13 大连信科化工有限公司 一种制备3-吗啉酮的方法
AU2018376146A1 (en) 2017-11-29 2020-05-28 Bayer Aktiengesellschaft Nitrogenous heterocycles as a pesticide
WO2019215076A1 (de) * 2018-05-08 2019-11-14 Bayer Aktiengesellschaft Verfahren zur herstellung stickstoffhaltiger heterocyclen
CN108715584B (zh) * 2018-06-22 2021-06-25 四川大学华西医院 以n-吡啶-2-(1h)-腈亚氨为母核的荧光分子及其制备与应用

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US66615A (en) * 1867-07-09 Steering apparatus
US279845A (en) * 1883-06-19 John d
US171358A (en) * 1875-12-21 Improvement in machines for trimming and punching roofing-slates
US293704A (en) * 1884-02-19 Windmill
US153876A (en) * 1874-08-04 Improvement in carbureting apparatus
US42015A (en) * 1864-03-22 Improvement in saddles
US185092A (en) * 1876-12-05 Improvement in check-rowers
US162690A (en) * 1875-04-27 Improvement in valves for steam-engines
US125052A (en) * 1872-03-26 Improvement in apparatus for checking horses
US112039A (en) * 1871-02-21 Improvement in plow-colters
US298806A (en) * 1884-05-20 Bag and twine holder
US259924A (en) * 1882-06-20 Sand-band
US197929A (en) * 1877-12-11 Improvement in boots and shoes
US241233A (en) * 1881-05-10 Wind-wheel
US29064A (en) * 1860-07-10 Lowering and detaching ships boats
US254036A (en) * 1882-02-21 Measuring-faucet
US100193A (en) * 1870-02-22 John ross
US186810A (en) * 1877-01-30 Improvement in machines for making metal fellies
US749217A (en) * 1904-01-12 Ho model
US63113A (en) * 1867-03-19 smith
US51578A (en) * 1865-12-19 Improvement in cigar-machines
US98119A (en) * 1869-12-21 Improved rocking and easy chair
US697135A (en) * 1901-03-07 1902-04-08 Henry W Scott Antislipping device.
US756037A (en) * 1903-03-21 1904-03-29 Angus Morrison Press-rack.
US836536A (en) * 1906-02-12 1906-11-20 Eagle Lock Co Suit-case lock.
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
US5919779A (en) 1997-08-11 1999-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. 5,6-Heteroaryl-dipyrido(2,3-B:3', 2'-F) azepines and their use in the prevention or treatment of HIV infection
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6644367B1 (en) * 1999-07-23 2003-11-11 Scholle Corporation Connector assembly for fluid flow with rotary motion for connection and disconnection
NZ517829A (en) 1999-09-17 2004-12-24 Millennium Pharm Inc Benzamides and related inhibitors of factor Xa
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
WO2001021160A2 (en) 1999-09-23 2001-03-29 Axxima Pharmaceuticals Aktiengesellschaft Carboxymide and aniline derivatives as selective inhibitors of pathogens
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US6906063B2 (en) 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
WO2001064642A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
DE10027151A1 (de) 2000-05-31 2001-12-06 Bayer Ag Herbizide Mittel auf Basis von substituierten Carbonsäureamiden
WO2002000651A2 (en) 2000-06-27 2002-01-03 Bristol-Myers Squibb Pharma Company Factor xa inhibitors
WO2002079145A1 (en) 2001-03-30 2002-10-10 Millennium Pharmaceuticals, Inc. BENZAMIDE INHIBITORS OF FACTOR Xa
US7312235B2 (en) 2001-03-30 2007-12-25 Millennium Pharmaceuticals, Inc. Benzamide inhibitors of factor Xa
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
US6914058B2 (en) 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
WO2003074501A1 (fr) 2002-03-07 2003-09-12 Sds Biotech K.K. Derive d'isoxazole alkylamine substitue et fongicide a usage dans l'agriculture et l'horticulture
JP3090812U (ja) 2002-06-18 2002-12-26 アルプス電気株式会社 高周波モジュール
WO2004101531A1 (en) 2003-04-29 2004-11-25 Dr. Reddy's Laboratories Ltd. Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them
DE10322469A1 (de) 2003-05-19 2004-12-16 Bayer Healthcare Ag Heterocyclische Verbindungen
WO2004106329A2 (en) 2003-06-03 2004-12-09 Dr. Reddy's Laboratories Ltd. Novel antiinfective compounds and their pharmaceutical compositions
US7199149B2 (en) * 2003-10-01 2007-04-03 Bristol Myers Squibb Company Monocyclic and bicyclic lactams as factor Xa inhibitors
ES2338881T3 (es) 2003-10-09 2010-05-13 Millennium Pharmaceuticals, Inc. Benzamidas sustituidas con tioeter como inhibidores del factor xa.
WO2005035528A2 (en) 2003-10-14 2005-04-21 Dr. Reddy's Laboratories Ltd. Triazole derivatives as antibacterial agents
WO2005082892A2 (en) 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
KR101195801B1 (ko) 2004-06-18 2012-11-05 밀레니엄 파머슈티컬스 인코퍼레이티드 Ｘａ 인자 억제제
US7696352B2 (en) 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
DE102004031258A1 (de) * 2004-06-29 2006-02-09 Jennissen, Herbert P., Prof. Dr. Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen
US20060002099A1 (en) * 2004-06-30 2006-01-05 Stoneham Edward B Electromagnetic shield assembly
US20080293701A1 (en) 2005-02-02 2008-11-27 Baldwin John J 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
AR057976A1 (es) * 2005-08-29 2008-01-09 Boehringer Ingelheim Int Biarilos sustituidos y su uso como medicamentos.
US20070208045A1 (en) 2005-11-03 2007-09-06 Portola Pharmaceuticals, Inc. Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
JP5227178B2 (ja) 2005-11-08 2013-07-03 ミレニアム ファーマシューティカルズ， インコーポレイテッド Ｎ−（５−クロロ−２−ピリジニル）−２−［［４−［（ジメチルアミノ）イミノメチル］ベンゾイル］アミノ］−５−メトキシ−ベンズアミド、第Ｘａ因子阻害剤の薬学的な塩および多形体
WO2007112367A2 (en) 2006-03-27 2007-10-04 Portola Pharmaceuticals, Inc. Potassium channel modulators and platelet procoagulant activity
EA015942B1 (ru) 2006-05-05 2011-12-30 Милленниум Фамэсьютикэлс, Инк. Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови
DE102006025314A1 (de) 2006-05-31 2007-12-06 Bayer Healthcare Ag Arylsubstituierte Heterozyklen und ihre Verwendung
US20080051578A1 (en) * 2006-08-24 2008-02-28 Georg Dahmann Substituted biaryls, process for their manufacture and use thereof as medicaments
ES2382055T3 (es) 2006-11-02 2012-06-04 Millennium Pharmaceuticals, Inc. Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa
KR101472765B1 (ko) 2006-12-08 2014-12-15 밀레니엄 파머슈티컬스 인코퍼레이티드 경구용 Ｘａ 인자 억제제를 포함하는 단위 용량 제형 및 경구용 Ｘａ 인자 억제제를 사용하는 혈전증의 치료 방법
JP2010515691A (ja) 2007-01-05 2010-05-13 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 第Ｘａ因子阻害剤
WO2008121721A2 (en) 2007-03-28 2008-10-09 Portola Pharmaceuticals, Inc. Targeted delivery and expression of procoagulant hemostatic activity
EP2591783A1 (en) 2007-04-13 2013-05-15 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
PT2146705E (pt) 2007-05-02 2014-05-23 Portola Pharm Inc Terapia de combinação com um composto que atua como inibidor do recetor de adp de plaquetas
EP3824902A1 (en) 2007-09-28 2021-05-26 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
CN102316893B (zh) 2008-11-14 2015-02-18 博尔托拉制药公司 因子Xa抑制剂的解毒剂及其与血液凝固剂组合使用的方法
EP2414517B1 (en) 2009-03-30 2016-09-21 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
JP6163304B2 (ja) 2009-07-15 2017-07-12 ポートラ ファーマシューティカルズ， インコーポレイテッド 第Ｘａ因子インヒビターの解毒剤の単位用量処方物およびその使用方法

Also Published As

Publication number Publication date
JP5227311B2 (ja) 2013-07-03
US8063077B2 (en) 2011-11-22
US7763608B2 (en) 2010-07-27
CN101490036A (zh) 2009-07-22
IL194891A0 (en) 2009-08-03
US7767697B2 (en) 2010-08-03
WO2007131179A1 (en) 2007-11-15
US20070259924A1 (en) 2007-11-08
EP2016072A1 (en) 2009-01-21
JP2009536218A (ja) 2009-10-08
AU2007247928B2 (en) 2013-06-13
NZ572418A (en) 2011-08-26
ZA200809362B (en) 2012-01-25
CA2651303A1 (en) 2007-11-15
KR20090010098A (ko) 2009-01-28
EA015942B1 (ru) 2011-12-30
TW200813017A (en) 2008-03-16
US20110118244A2 (en) 2011-05-19
HK1126490A1 (en) 2009-09-04
US20120088795A1 (en) 2012-04-12
US20090030045A1 (en) 2009-01-29
US8349873B2 (en) 2013-01-08
IL194891A (en) 2014-06-30
AR060768A1 (es) 2008-07-10
ZA201007095B (en) 2011-06-29
AU2007247928A1 (en) 2007-11-15
CN101490036B (zh) 2013-07-17
US20100249117A1 (en) 2010-09-30
BRPI0711296A2 (pt) 2011-08-23
MX2008014193A (es) 2009-03-31
EP2016072B1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
EA200802288A1 (ru) Замещенные имидазолы, композиция на их основе, способ профилактики или лечения нежелательного тромбообразования с их помощью и способ ингибирования коагуляции образцов крови
WO2008086226A3 (en) Factor xa inhibitors
WO2008086188A3 (en) Thiophene carboxamides as factor xa inhibitors
EA201101583A1 (ru) Ингибиторы pi3 киназы или mtor
WO2006002099A3 (en) Factor xa inhibitors
EA200900178A1 (ru) Конденсированные гетероциклические производные и их применение
UA99361C2 (ru) ТРИАЗИНЫ КАК ИНГИБИТОРЫ PI3-КИНАЗЫ I mtor
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
EA201001159A1 (ru) Конденсированные гетероциклические производные и их применение
EA200702339A1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
EA201001619A1 (ru) Ингибиторы протеинкиназ
ATE540932T1 (de) Hydantoin-derivate als antibakterielle wirkstoffe
WO2009131687A3 (en) Inhibitors of protein kinases
EA200971115A1 (ru) Новые ингибиторы обратной транскриптазы вич
EA201100391A1 (ru) Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы
EA200802058A1 (ru) Производные циклоалкиламинокислот и их фармацевтические композиции
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
EA201100447A1 (ru) Органические соединения
EA200971104A1 (ru) Производные бензимидазола
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
WO2006063113A3 (en) Ureas as factor xa inhibitors
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
EA201001618A1 (ru) Ингибиторы syk протеинкиназ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU